Gout: patient education and non-pharmacological treatments

In the second part of a two part series, Diana Finney focuses on the management of gout in the care home setting and includes pharmacological and non-pharmacologic management ideas

[1]  M. Doherty,et al.  Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study , 2012, Annals of the rheumatic diseases.

[2]  Charles King,et al.  2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia , 2012, Arthritis care & research.

[3]  R. Terkeltaub,et al.  High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. , 2010, Arthritis and rheumatism.

[4]  J. Wozniak,et al.  Gout: overview and newer therapeutic developments , 2010 .

[5]  Mariann Montgomery.  Gout: Tips on diagnosis, treatment, and patient education. , 2008, The Nurse practitioner.

[6]  H. Schumacher,et al.  Gout: an evidence-based review. , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[7]  H. T. ter Laak,et al.  Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin. , 2008, The Netherlands journal of medicine.

[8]  P. Emery,et al.  Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra , 2007, Annals of the rheumatic diseases.

[9]  M. Malaguarnera,et al.  Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout , 2007, International journal of medical sciences.

[10]  F. Sivera,et al.  Therapeutic advances in gout , 2007, Current opinion in rheumatology.

[11]  N. Schlesinger.  Response to Application of Ice May Help Differentiate Between Gouty Arthritis and Other Inflammatory Arthritides , 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[12]  P Netter,et al.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.

[13]  T. Hart,et al.  Genetic factors associated with gout and hyperuricemia. , 2006, Advances in chronic kidney disease.